Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.
G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...
Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...
BRINP2-related peptide, or BRP, is a naturally occurring molecule that can suppress appetite and promote weight loss in mice ...
Weight loss drugs like Ozempic deliver more health benefits than expected.
Novo Nordisk launched "My Ozempic® Era" today, a national campaign which spotlights the longstanding Ozempic® patient ...
With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.
State DHS officials say new weight-loss drugs are driving up costs for Pennsylvania’s Medicaid program, likely leading to ...
"Studies have shown benefits in worsening kidney disease, heart failure and obstructive ... effect of a gaunt face (colloquially called "Ozempic face"), particularly in patients with less skin ...